Our research into rare cancers

120 years of life-saving discoveries

Our scientists have been at the forefront of cancer research since 1902.

Thanks to you, we’ve come so far. And we will go much further.

Together, we will beat cancer.

 

Donate now

Our research is saving lives

Together, rare cancers make up more than 20% of all cancer cases. We’ve contributed to several advances for people with rare cancers. We ran some of the first trials for people with uveal melanoma and neuroendocrine tumours, and showed that the drug Glivec was effective for some advanced gastro-intestinal stromal tumours (GIST). And we set up and continue to support the International Rare Cancers Initiative, which is developing clinical trials worldwide to find new treatments for rare cancers.

Rate this page:

Currently rated: 2.7 out of 5 based on 23 votes
Thank you!
We've recently made some changes to the site, tell us what you think